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Protocols for the analysis of the sulfhydryl content in peptides and proteins using chemical 
derivatization by organomercurial reagents and analysis by matrix-assisted laser desorption 
ionization mass spectrometry (MALDI-Ms) have been developed. The number of reactive 
cysteine residues in peptides and proteins can be determined by exploiting the affinity and 
selectivity of organomercurial reagents for macromolecular thiols. Mass shifts observed in 
MALDI mass spectra obtained before and after cysteine derivatization with p-hydroxy- 
mercuribenzoate (pHMB) permit the number of free sulfhydryl groups to be determined. The 
pHMB derivative of each free cysteine residue provides a mass shift of 321 u, overcoming 
limitations in the mass resolution of MALDI time-of-flight mass spectrometry. Reactive 
cysteine residues in a macromolecule can be selectively derivatized by using a fivefold molar 
excess of pI-IMB reagent. Total sulfhydryl content (i.e., cysteine and cystine) can be deter- 
mined after disulfide reduction. However, analyses for total cysteine content are more 
complex, requiring protein denaturation, cystine reduction, and sample purification before 
derivatiaation and analysis by MALDI-MS. Conditions for sample denaturation, alkyl-phos- 
phine reduction, pHMB derivatization, and sample purification by analyte adsorption and 
desalting on protein transfer membranes, are described for cysteine/cystine analysis per- 
formed on microgram (K-200 pmol) quantities of somatostatin, insulin, hemoglobin, and 
&lactoglobulin. IJ Am Sot Mass Spectrum 1994, 5, 359-366) 
N 
umerous methods for the quantitative deter- 
mination of free sulfhydryl groups (cysteine) 
and disulfide-bonds (cystine) in proteins are 
based on selective reactions in which thiols participate. 
The most precise and commonly used methods involve 
spectrophotometric titrations with mercaptide-forming 
compounds [l, 21 or alkylating reagents [3, 41, while 
others incorporate amino acid analysis following con- 
version of cysteine to cysteic acid [5] or to an alkyl 
derivative [4,6,7]. Major limitations in the spectropho- 
tometric titration of macromolecular thiols are the rela- 
tively large sample size requirement (in the milligram 
range) and the uncertainty in determination of the end 
point. Although amino acid analyses can be performed 
at the microgram level, differentiating between free 
cysteine residues and those involved in disulfide bonds 
(cystines) can be cumbersome, as this involves first 
modifying the initially free sulfhydryl groups, remov- 
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ing the excess reagents, reducing the disulfide bonds, 
then modifying the nascent sulfhydryl groups in a way 
that allows for their recognition [S, 91. Furthermore, 
because amino acid analysis provides information on 
the total amino acid content of the sample, a protein 
contamination of only 10% could lead to an error of 
10% or more in the quantitation of derivatized cysteine 
residues. 
Mass spectral analysis of derivatized macromolecu- 
lar thiols is an alternative means of quantitatively 
assessing protein cysteine/cystine content in a way 
that promises to overcome limitations of sensitivity, 
multiple derivatizations, and protein contamination 
that burden the more classical methods. Because het- 
erogeneous protein samples can be analyzed at the 
picomole level by matrix-assisted laser desorption ion- 
ization mass spectrometry (MALDI-MS) [lo, 111, anal- 
ysis of the mass spectral shifts associated with selec- 
tive chemical derivatization of the analyte has the 
potential to become a sensitive means for analyzing 
the sulfhydryl content of peptides and proteins. 
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One means to selectively derivatize macromolecular 
thiols exploits the reactivity they display toward metal 
ions. Although many monovalent and divalent metal 
ions can react with sulfhydryl groups, mercurial 
reagents are known to be especially selective for thiols 
because the strong mercury-sulfur affinity greatly ex- 
ceeds the interactions that may occur between mercury 
and other types of reactive groups typically present in 
a protein [ 121. However, divalent mercuric ions (Hg ’ +> 
are capable of reacting in a way to “bridge” two thiol 
groups [131, and also have the potential of reacting 
with existing disulfide bonds. In contrast, monofunc- 
tional organomercurial compounds of the type RHgX 
have the advantage of only reacting with one thiol 
group. A commonly used compound in this class (Fig- 
ure la) is p-hydroxymercuribenzoate (pHMB), which 
has been used in the spectrophotometric and ampero- 
metric determination of sulfhydryl groups in proteins 
[14, 151. 
We report here a new method of determining the 
number of cysteine and cystine residues present in 
peptides and proteins using chemical derivatization by 
a monofunctional organomercurial reagent prior to 
analysis by MALDI-MS. In these analyses, a peptide or 
denatured protein is first allowed to react with a 
monovalent organic mercurial reagent in the absence 
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Figure 1. (a) Structures of organomercurials used for derivatiza- 
tion of sulfhydryl groups in proteins prior to analysis by MALDI- 
MS. (b) According to the reaction scheme, derivatization of each 
sulfhydryl group causes a mass shift of 321 u for pHMB (and 357 
u for pHMBS and 690 u for merbromin). 
of a disulfide reducing agent to selectively label any 
free sulfhydryl group(s). Parallel experiments using 
underivatized protein provide mass spectral data from 
which to calculate the number of free sulfhydryls by 
the shift in the molecular weight of the organomercu- 
rial/protein derivative relative to that of the native 
protein. In the case for pHMB, a mass shift of 321 u 
units is observed for each derivatized cysteine of the 
protein ~Figure lb). A complementary experiment in- 
volving the same reaction, after exposure of the sam- 
ple to a disulfide reducing reagent, provides mass 
spectral data that allow for differentiation of the total 
number of cysteine(s) and/or cystine(s) originally 
present. Conditions for protein denaturation, cystine 
reduction with alkyl-phosphine reagents, pHMB 
derivatization, and sample purification by analyte ad- 
sorption on protein transfer membranes following re- 
moval of excess reagent by aqueous washing are de- 
scribed for the select&e and sensitive determination of 
cysteine/ cystine residues in proteins on microgram 
quantities of sample. 
Experimental 
MALDf mass spectra were obtained on a Vestec 
LaserTec Research (Vestec Corp., Houston, TX) time- 
of-flight (TOF) mass spectrometer equipped with a 
nitrogen laser (337nm, 3-ns pulse). The accelerating 
voltage in the ion source was set to 28 kV. Data were 
acquired in the linear mode of operation, using a 
500~Mhz transient recorder with 1-ns resolution. Each 
spectrum was produced by accumulating data col- 
lected from 64 laser shots. Time-to-mass conversion 
was achieved by internal calibration using standards 
of bradykinin, oxidized insulin B chain, or insulin (5 
pmol of each standard) obtained from Sigma Chemical 
Co. (St. Louis, MO). 
Derivatization was performed with p-hydroxy- 
mercuribenzoate (pHMB, Sigma), p-hydroxymercuri- 
phenylsulfonate (pHMI’!$ Sigma), or merbromin (Fluka 
Chemie AG, Buchs, Switzerland). Approximately 500 
mg of pHMB reagent were washed with 1.0 mL of an 
aqueous 0.1% trifluoroacetic (TFA) acid solution three 
times to remove contaminating mercuric (Hg++) salts, 
filtered, and dried before using. Solutions of the pHMB 
(2.8 mg/mL) were prepared freshly in either 0.1% 
NHPH or 0.1% NH,OH made 4 M in urea and 
vortexed until dissolved. Merbromin and pHMl’!S were 
used as supplied. Hemoglobin samples were supplied 
by Dr. T. Yang, Department of Chemistry, University 
of Wisconsin-Eau Clare, Eau Clare, Wisconsin. All other 
peptides and proteins were purchased from Sigma. 
Peptide and protein samples (3.0 pg unless otherwise 
stated) were solubiltied in 5.0 PL of either 0.1% 
NH,OH or 0.1% NH,OH made 4 M in urea as de- 
scribed in the text. Reduction of cystine was performed 
with a solution of tri@carboxyethyl)phosphine hy- 
drochloride (TCEP, purchased from Pierce, Rockford, 
IL) prepared in 0.1% NH,OH to provide a twofold 
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molar excess of the reducing reagent over cystine in a 
water bath at 37 “C for 20 minutes. Derivatization of 
the free sulfhydryl groups was achieved by adding a 
fivefold molar excess of the organomercurial reagent 
(over free cysteine) and reacting for 5-20 minutes at 
room temperature. Samples containing urea were de- 
salted by diluting twentyfold with a 1:l solution of 
acetonitrile/aqueous 0.1% TEA, then applying 2.0-PL 
aliquots of the mixture to pieces of Zetabind immobi- 
lization membrane (Cuno Laboratory Products, pur- 
chased from Life Science Products Inc., Denver, CO> 
fixed to the LaserTec probe tip by double-sided adhe- 
sive tape 1161. After drying of the sample on the 
membrane, the probe tip was immersed in water to 
remove the urea. This procedure was repeated 3-10 
times, depending on the final sample volumes, to 
concentrate analyte while removing excess urea. 
All experiments were performed using cw-cyano4- 
hydroxycinnamic acid (Aldrich Chemical Co., Milwau- 
kee, WI) as the matrix. Saturated matrix solutions were 
prepared in a 1:l solution of acetonitrile/aqueous 0.1% 
TEA containing internal standards, and mixed in equal 
volumes with the peptide/protein sample and applied 
to a stainless-steel probe tip. Otherwise, matrix solu- 
tion containing internal standards was applied to the 
probe-mounted Zetabind membrane containing the ad- 
sorbed protein sample. Matrix-protein solutions were 
allowed to “air-dry” and crystallize on the membrane 
surface prior to introduction into the mass spectrome- 
ter [161. 
Results and Discussion 
Derivatization of Peptides with pHMB 
Evaluation of the new methodology and behavior of 
the organomercurial, p-hydroxymercuribenzoate 
(pHMB), were initially studied with somatostatin, a 
14-residue peptide containing one cystine (MW = 
1637.9). The MALDI mass spectrum shown in Figure 
2a was recorded from a 15-pmol sample of somato- 
statin. No modification of the peptide was observed 
when mass spectral data were acquired from samples 
prepared in the presence of up to twenty-fivefold mo- 
lar excess of pHMB (and in the absence of a reducing 
reagent), indicating no insertion of the organomercu- 
rial reagent into the disulfide bond. During incubation 
with a twofold molar excess of TCEP for 20 minutes at 
37 “C, the cystines of similar somatostatin samples 
were completely reduced, as confirmed by the MALDI 
mass spectrum in Figure 2b, which shows a peak at 
m/z 1640.7, [M + HI&,= = 1640.9. A similarly reduced 
sample of somatostatin was then incubated with a 
fivefold molar excess of pHMB for 5 minutes at room 
temperature and analyzed by MALDI directly after 
cocrystallization with the matrix. The MALDI mass 
spectrum in Figure 2c shows that the latter procedure 
results in derivatization of both liberated cysteine 
residues that constituted the disulfide bond, shifting 
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Figure 2. MALDI mass spectrum of (a) 15 pmol of somatostatin, 
[M + Hl,+,,c = 1638.9; (b) 15 pm01 of somatostatin following re 
duction, [M + HI:,, = 1640.9; and (c) 15 pm01 of reduced so- 
matostatln after reaction with a fivefold molar excess of pHMB 
over total cyst&e. Peaks recorded at m/z 1961.6 and 2282.4 
represent derivatization of one and both free cyst&e residues, 
respectively. 
the mass of the analyte by (321 X 1) u to [M + HI&,= 
= 1961.9, and by (321 X 2) u to [M + HILk = 2282.9. 
Assignments were also made for the minor peaks in 
Figure 2b and c, representing either an adduct or 
complex of modified somatostatin with ot-cyano4- 
hydroxycinnamic acid (see section on Competing Side 
Reactions, below). 
Derivatization of Proteins with pHMB 
Proteins may contain cysteine, cystine, or a combll- 
tion of both these functionalities. To fully characterize 
these groups for most proteins it will be necessary to 
ensure that the macromolecule is sufficiently dena- 
tured to derivatize sulfhydryl groups that may not be 
accessible in the folded, native state (“masked cys- 
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teines”). Because reduced and denatured proteins of- 
ten tend to precipitate, solubility is typically main- 
tained with a high concentration (2-6 Ml of chaotropic 
reagents, such as urea or guanidine hydrochloride, in 
the reaction medium. However, before analysis of the 
sample by MALDI-MS, the denaturing agents must be 
removed. Standard procedures for desalting like dialy- 
sis or gel filtration cause significant protein losses 
when applied to low-level samples (i.e., 1 pg or less); 
therefore, we have employed a recently developed 
membrane-based sample cleanup procedure (ref 16, 
see Experimental). 
Insulin was chosen as a model compound for analy- 
sis of a protein containing only disulfide bonds. Bovine 
insulin (MW = 5733.5) consists of three disulfide 
bonds, two intermolecular bonds between the insulin 
A-chain (reduced MW = 2339.7) and the B-chain (re- 
duced MW = 3399.91, and one intramolecular disulfide 
bond located within the Arhain. Treatment of native 
insulin with pHMB did not result in modification of 
the analyte, IM + HI& = 5734.7 (data not shown). 
Figure 3a shows the negative ion MALDI mass spec- 
trum recorded from a sample of insulii following 
reduction with TCEP. The two predominant peaks in 
the spectrum represent the reduced A- and B-chains. 
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Figure 3. MALDI negative ion mass spectrum of (a) 17 pm01 of 
reduced bovine imulii displaying peaks for the A- and B-sub- 
units; (b) 17 pm01 of reduced bovine insulin after reaction with 
pHMB. Peaks marked with asterisks represent an oxidation of 
cysteine to cyst&c acid (48 u mass shift). See Table 1 for correla- 
tion of experimentally determined (Figure 3b) values of mass-to- 
charge ratios with calculated values of mass-to-charge ratios for 
indicated structural formulae. 
J Am Sot Mass Spectrom 1994,5,359+366 
In contrast, the positive ion MALDI mass spectrum 
(data not shown) only showed a single peak represent- 
ing the reduced form of the insulin B-chain. The ab- 
sence of a peak for the reduced A-chain of insulin in 
the positive ion MALDI mass spectrum has been re- 
ported by others 1171, and may be related to the num- 
ber of acidic residues present in the peptide. Reduction 
was nearly complete using a twofold molar excess of 
TCEP (over cystine) as determined by the near absence 
of a signal for native insulin in either the positive or 
negative MALDI-MS mode. ln these experiments with 
insulin, it was necessary to process the protein in 4 M 
urea because of insolubility of the reduced insulin 
A-chain. The MALDI mass spectrum shown in Figure 
3b was recorded from a reduced sample of insulin that 
was derivatized with pHMB. Although the mass spec- 
trum is complex, showing a multiplicity of peaks cor- 
responding to partially derivatized species with quan- 
tized mass shifts of 321 u for each pHh4B (or 201 u for 
each mercury) added, peaks shifted to m/z 3622 (A- 
chain) and m/z 4041 (B-chain) indicate that all six 
cysteine residues of bovine insulin can be accounted 
for by pHMB derivatization. Table 1 lists the calcu- 
lated and observed mass-to-charge ratio values for all 
products of the reaction between pHMB and the indi- 
cated number of SH groups. The spectrum in Figure 3b 
indicates that some cysteines were oxidized to cysteic 
acid, producing a mass shift of 48 u for every cysteic 
acid residue (peaks identified by asterisks). Metal ions 
are known to act as catalysts in the oxidation of cys- 
teine to cysteic acid [18], therefore the pHMB may 
have acted as a catalyst in the oxidation process. How- 
ever, some oxidized products of insulin A and B chain 
can be observed prior to treatment with pHMB (Figure 
3a). 
Hemoglobin A (HbA) was chosen as a model com- 
pound for thiol group analysis of a protein containing 
only free cysteine. Human hemoglobin A consists of an 
n-chain with one free cysteine (MW = 15,126) and a 
P-chain with two free cysteines (MW = 15,867). The 
MALDI mass spectrum in Figure 4a, recorded from a 
100-pmol sample of dehemed human hemoglobin A, 
shows peaks representing the protonated molecules for 
Table 1. Calculated and observed masses for pHMB- 
derivatized A- and B-chains of reduced bovine insulin 
Subunit chain LM - HI,,, IM - HI,, 
A 2338.7 2338.4 
A+1 pHMB 2659.7 2659.5 
A+2pHMB 2960.7 2980.4 
A+2pHMB+l Hg 3181.3 3179.2 
A+3pHMi3 3301.7 3302.9 
A+3pHMB+l Hg 3502.3 3503.5 
A+4pHMB 3622.7 3622.4 
8 3398.9 3399.3 
E+l pHMB 3719.9 3720.8 
B+2pHME 4040.9 4041 .l 
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Figure 4. MALDI mass spectrum of (a) a mixture of IY- and 
p&bin chains (approximately 100 pmol) of human hemoglobin 
A (HbA). IM + Hl+,_ = 15,127 and 15,868, resaectivelv; (b) a 
mixture of -cc- and w‘~glob& chaii (ap&&&ly 100 &nol) of 
HbA following derivatization with pHMB. The peak at m/z 
15,451 represeks modification of the single cyst&e in the u- 
globii chain, while the peak at m/z 16,512 indicates that both 
cyst&es in the pglobin chain were derivatized. 
both the (Y- and -hains. Because the globin chains 
were readily soluble in 0.1% NH,OH, a urea denatu- 
rant was not used for these experiments. Figure 4b 
shows the MALDI mass spectrum recorded from an- 
other similar aliquot of a hemoglobin A sample that 
had been treated with a fivefold molar excess of pHMB 
for 5 minutes. Assigned peaks (Figure 4b) correspond 
to pHMB modification of the single cysteine in the 
HbA a-chain shifting its mass by (321 X 1) u to [M + 
HI&, = 15,448, and the two cysteine residues in the 
HbA @hain, shifting its mass by (321 x 2) u to [M + 
HI& = 16,510. Thus, the organomercurial derivatiza- 
tion approach can be applied to cysteine analysis in a 
mixture of proteins. Classical means of analyzing this 
sample would result in quantitation of only the total 
cysteine content of the mixture unless a separation was 
performed prior to analysis. However, assessment of 
the mass shifts recognized by comparing Figure 4a and 
b correctly correlates with the known cysteine content 
for the mixture of human hemoglobin (z- and @chains. 
The milk protein &lactoglobulin (MW = 18,367) 
was selected as a model protein containing both cys- 
teine and cystine groups. This protein consists of five 
cysteine residues, four of which make up two disulfide 
bonds, and one of which is free. The MALDI mass 
spectrum of the unmodified protein (Figure 5a) shows 
a major peak at m/z 18,375 ([M + HI& = 18,368 u>, 
and a minor trailing shoulder at m/z 18,674. The 
source of this shoulder is unknown, but it was found 
in mass spectra obtained from samples of the protein 
procured from two different sources (one being se- 
quencing grade plactoglobulin). Because at least four 
different forms of P-lactoglobulin are known to exist 
(one of which is glycosylated), we believe that the 
trailing peak likely results from analysis of heteroge- 
neous samples containing different protein forms. The 
MALDI mass spectrum of unreduced and pHMB-mod- 
ified @-lactoglobulin (Figure 5b) shows that reaction 
with the organomercurial reagent shifted both peaks in 
Figure 5a by 321 u, suggesting that the trailing shoul- 
der likely represents a structurally related impurity. 
Native /34actoglobulm was derivatized in the absence 
of urea as it was readily soluble in 0.1% NH,OH. 
However, reduced Plactoglobulin required urea for 
solubilization. The MALDI mass spectrum shown in 
Figure 5c was obtained from a sample of plactoglob- 
ulin that was denatured in 4 M urea, reduced with a 
twofold molar excess of TCEP (over cystine), deriva- 
tized with a fivefold molar excess of pHMB (over 
cysteine), and desalted/concentrated on a protein 
transfer membrane fixed to the MALDI probe tip. 
Peaks that can be assigned to species resulting from 
derivatization of all five cysteine residues in plactc+ 
globulin are observed. Even though the peak repre- 
senting the fully derivatized protein is small, [M + 
HI& at m/z 19,974, its assignment is not ambiguous. 
The mass shift of the predominant peak in Figure 5a to 
m/z 18,695 in Figure 5b shows that a single cysteine is 
present in the unreduced protein. Reduction of each 
disulfide bond will liberate two sulfhydryl groups, 
which can be derivatized by pHMB. Therefore, in the 
spectrum of the reduced/derivatized sample (Figure 
5~1, the three peaks at m/z 19,018, 19,327, and 19,644 
are expected to be accompanied by a fourth peak 
corresponding to a fully derivatized species. The low 
abundance of the fully derivatized protein may have 
several causes. First, even after denaturation, 
sulfhydryl groups in large proteins may not be com- 
pletely accessible to the derivatizing reagent. It is also 
possible that cysteine oxidation is competing with 
pHMB derivatization. However, we have demon- 
strated that complete derivatization of insulin can be 
accomplished with good yield even in the face of 
competing oxidation (Figure 3b). We are currently in- 
vestigating modification of reaction conditions for 
larger proteins to improve the yield of the fully deriva- 
tized products. 
Choice of a Mercurial Reagent for Sulfhyd yl 
Derivatization 
Although numerous types of reagents are available for 
derivatization of macromolecular thiols, mercury com- 
pounds were chosen for several reasons, but primarily 
because of the selective reactivity of mercury for 
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Figure 5. MALDI mass spectrum of (a) 71 pm01 of bovine 
/?-lactoglobulin A, [M + HI;,,, = 18,368; (b) 11 pm01 of placto- 
globulin A following derivatization of the single free cysteine 
with pHMB under nonreducing conditions [M + HI;,, = 18,688; 
Cc) 11 pmol of denatured and reduced P_lactoglobulin A follow- 
ing derivatization with pHMB. Peaks in c represent modified 
analogs of the reduced analyte with progressively increasing 
numbers of pHMB with the available free-SH groups listed in the 
insert. 
sulfhydryl groups. Sufficient selectivity is not always 
achieved with many types of alkylating reagents such 
as the maleimides, which have been found to react 
with the imidazole group of histidine and the a-amino 
group of amino acids [191. Similarly, the haloacids and 
their amides, also popular reagents for sulfhydryl 
derivatization, have been found to react with the 
thioether group of methioniue [20]. On the other hand, 
mercury compounds are highly specific reagents for 
the derivatization of sulfhydryl groups. The selectivity 
is related to the strong mercury-sulfur interaction; the 
dissociation constants for the mercaptide formed be- 
tween mercuric ion (Hg”) and cysteine or methyl 
mercury (CH,Hg+) and cysteine are 10-i5.’ and 
10-20.3, respectively 1211. Although mercuric ions show 
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the strongest binding to sulfbydryl groups, they are 
not suitable derivatizing reagents because divalent 
mercury will form mercaptides of the type (RS),Hg 
[131, which will produce anomalous mass spectral re- 
sults. Monovalent organomercurials, however, are only 
capable of forming mercaptides of the type (RS)HgR, 
and will only cleave disulfide bonds and react with the 
liberated sulfhydryl groups under harsh conditions 
(i.e., high concentration of the organomercurial, ele- 
vated temperatures, and prolonged incubation times) 
WI. 
Another reason for our choice of organomercurial 
reagents is that these compounds promote large mass 
shifts in the mass spectrum of the derivatized protein. 
This is important in the analysis of large proteins by 
MALDI-TOF-MS where mass resolution is limited. 
In this report we have primarily investigated p-HMB 
and p-HMPS as derivatizing reagents that promote 
mass shifts of 321 u and 357 u, respectively. Although 
pHMPS and pHMB produced similar results in classi- 
fying sulfhydryl groups as being either cysteine or 
half-cystine, only data obtained from pHMB are pre- 
sented hem because of its convenient purification. 
MALDI-MS data obtained from peptides and proteins 
derivatized with pHMl’S contained significantly more 
peaks, representing modification of the macromolecule 
by mercuric ion (201 u mass shift). We also have 
derivatized sulfhydryl groups with organomercurials 
such as merbromin (Figure 1 al, which produces a mass 
shift of 690 u. While CH,Hg+ has been used in amper- 
ometric titrations [15], it was not used in. this work 
because it was not readily available. 
Many of the organomercurial compounds consid- 
ered for this application were contaminated by mer- 
curic ion, which produced additional peaks in the 
MALDI mass spectra. This contamination may arise 
from photodegradation as many organomcrcurial com- 
pounds are light-sensitive. Even though the mercuric 
ion contamination may be very small, the high affinity 
of mercuric ion for sulfhydryl groups (over that of 
monovalent organomercurials) will produce signifi- 
cant mercuric ion derivatization. Purification of the 
organomercurial compound prior to its use is therefore 
essential for desirable derivatization of the peptide or 
protein. Although merbromin and pHMPS (Figure la) 
are readily soluble in either acidic or basic aqueous 
solutions, pHMB is only soluble in basic solutions (2.8 
mg/mL at a pH above 10.0). We made use of the 
relative insolubility of pHMB in acidic conditions to 
purify it by washing with 0.1% TEA (pH = 2.2) prior 
to its use. This treatment conveniently removes most 
of the mercuric ion contamination. Because of its lim- 
ited solubility at low or neutral pH, pHMB derivatiza- 
tion requires all reactions to be performed under basic 
conditions. Therefore, reactions were conducted in so 
lutions containing 0.1% NH,OH (pH = 10.8). Disul- 
fide bonds can be cleaved in alkaline media 1231, but 
we found that cleavage will not occur if derivatization 
reactions are performed in less than 30 minutes. 
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We found that derivatization of peptides and pro 
teins occurred in less than 5 minutes using basic condi- 
tions. Reagents such as pHMB or pHMPS are expected 
to be less reactive under basic conditions in which 
association of hydroxide ion and the mercury sub- 
stituent of the organomercurial is favored [22]. How- 
ever, because the reactive form of the sulfhydryl group 
is the ionized thiolate, performing the reaction under 
acidic conditions would have the adverse effect of 
limiting the reactivity of the sulfhydryl group. 
a 
Choice of Reducing Reagent 
Common reducing reagents for proteins such as mer- 
captoethanol or dithlothreitol cannot be used in the 
derivatization procedures described in this report be- 
cause they will react with the organomercurial reagent. 
Our preliminary experiments indicated that 100 mM 
sodium borohydride was an effective reducing reagent, 
but if excess reagent was not completely destroyed 
and removed, it interfered with the matrix-analyte 
crystallization process and prevented the acquisition of 
useful MALDI spectra. Also, we found that in some 
experiments utilizing sodium borohydride reduction, 
spurious MALDI-MS signals were recorded. This was 
likely due to peptide bond cleavage by the sodium 
borohydride, as has been reported by others 1241. Ter- 
tiary phosphines are known to be powerful reducing 
reagents that cause no modification of residues other 
than cystine and are effective in stoichiometric ratios 
1251. Although many tertiary phospbines are insoluble 
in aqueous media and have to be used as suspensions, 
we chose TCEP because of its water solubility [26]. 
TCEP is an effective reducing reagent under basic 
conditions, requires no more than a twofold molar 
excess (over cystine) for complete reduction of disul- 
fide bonds, and does not interfere with the matrixana- 
lyte crystallization process prior to analysis by 
MALDI-MS. 
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Figure 6. MALDI mass spectrum of (a) reduced somatostatin 
(15 pmol) that was exposed to wcyano-4-hydroxycinnamic acid 
matrix for 12 hours prior to obtaining the h4ALDI mass spec- 
hum. Peaks recorded at m/z 1829.6 and 2018.3 represent modi- 
fication of the peptide with one and two cu-cy.m-bhydroxycirr 
namic acid moieties, and the peaks recorded at m/z 3279.3 and 
3468.4 represent a disulfide exchange reaction that occurred be- 
tween two somatostatin peptides and modification of the two 
somatostatin peptides by one a-cyano4hydroxyci .acid 
moiety. Spectrum b was obtained from an aliquot (15 pmol) of 
the somatostatin sample used to record the mass spectrum shown 
in Figure Zc, but after remaining in the pHMB reaction mixture 
for 24 hours, showing modification of the reduced peptide with 
mercuric ion. The peak at m/z 2868.1 represents doubly charged 
insulin. 
Competing Side Reactions 
Because thiols also can add across polarized or easily 
polarizable double bonds [27], reaction with matrices, 
especially the cinnarnic acid derivatives, would be 
anticipated. This type of competing reaction can be 
seen in the MALDI mass spectrum obtained from a 
reduced sample of somatostatin analyzed by using 
cY-cyano-4-hydroxycinnamic acid as the matrix (Figure 
6a). After 12 hours of exposure of somatostatin to 
matrix (solid phase) on a stainless-steel probe tip, data 
were recorded showing extensive reaction of both cys- 
teine residues with a-cyano+hydroxyciamic acid. 
The abundance of the matrix-thiol derivative observed 
in Figure 6a, [M + HI& = 1829.6 ([M + HI,+,,, = 
1830.8), is nearly the same as that of the protonated 
molecule of somatostatin. In contrast, matrix-adduct 
ions typically have only about 5% (or less) of the 
abundance of the protonated analyte in the typical 
MALDI mass spectrum. Other peaks assigned in Fig- 
ure 6a represent somatostatin modified by two IY- 
cyano4-hydroxycinnamic acid groups, a dimer of so- 
matostatin (disulfide exchange product), and a dimer 
of the somatostatin matrix complex (see legend to 
Figure 61. 
We have found that matrix-cysteine reaction prod- 
ucts are formed in the solid phase, in a time-dependent 
manner. However, if cysteine-containing peptides are 
analyzed immediately after sample preparation, much 
less reaction of the analyte with a-cyano-4-hydroxycirt 
namic acid is observed. The pH of the derivatizing 
solution is also important in the modification of cys- 
teinyl peptides/proteins by matrices such as a-cyano- 
4-hydroxycinnamic. Adjusting the pH of the solution 
containing the analyte below pH = 3.0 maintains the 
thiol groups in protonated form, and thus minimizes 
the formation of matrix-thiol addition products. Alter- 
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natively, “matrix derivatization” of sulfhydryl-con- 
taining analytes can be avoided by using a matrix less 
reactive towards sulfhydryl groups (e.g., 2,5-dihy- 
droxybenzoic acid) or by driving the organomercurial- 
sulfhydryl reaction to completion before adding ma- 
trix. The latter solution, however, will not always be 
effective because a large excess of organomercurial 
reagent is required, which also may promote adverse 
side reactions such as the reduction of disulfide bonds 
D21. 
Another competing reaction sometimes observed 
was the modification of cysteine with mercuric ion or 
other mercury contaminants that may be present in the 
derivatizing reagent. Although the pHM3 used in all 
experiments was washed prior to its use, some con- 
taminating mercuric ion remained. As was the case in 
minimizing matrix-thiol derivative formation, we also 
have observed that modification of analyte sulfhydryl 
groups by contaminating mercuric ion can be mini- 
mized by analyzing samples immediately after deriva- 
tization and matrix cocrystallization. The consequence 
of prolonged derivatization reaction times can be seen 
in Figure 6b, which is the MALL)1 mass spectrum 
obtained from an aliquot of the same sample used to 
obtain the data in Figure Zc, but after remaining in the 
reaction mixture for 24 hours. Only peaks correspond- 
ing to reduced somatostatin, and somatostatin, modi- 
fied by one mercuric ion can be seen. The data in 
Figure 6 show that with time mercuric ion can displace 
the organomercurial reagent, even though the concen- 
trationof mercuric ions may be very low. This result is 
expected, given the much higher association constants 
of mercuric ion for cysteine over that of an organomer- 
curia1 compound [21]. Derivatization of a peptide with 
merbromin was successful in promoting a mass shift of 
the analyte by 690 u; however, many other unassigned 
signals were observed, indicating the need for purifi- 
cation of such compounds prior to their use as deriva- 
tizing reagents. 
nition of modified analyte molecules, despite the in- 
herent limitations in mass resolution of this technique. 
Appropriate treatment of the protein with denaturing 
and reducing agents prior to derivatization by 
organomercurials and subsequent analysis by MALDI- 
MS can provide data related to the number of free 
sulfhydryls and disulfide bonds present. Experiments 
performed in the presence of a denaturant will provide 
information about free and masked cysteines. Our 
studies have demonstrated that reagent purification 
and expeditious analysis of the sample after derivati- 
zation minimizes potential side reactions that could 
complicate spectral interpretation. Continuing work in 
this area will be directed toward improving the reac- 
tion efficiency and extending the methodology to sub- 
microgram samples. 
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